- Home
- Peg-Religrast 6Mg/0.6Ml Inj
Peg-Religrast 6Mg/0.6Ml Inj Substitute
Verified Ingredients and Effects
Composition:
PEGFILGRASTIM-6MG
Uses:
<p>Peg-Religrast 6Mg/0.6Ml Inj is used in the treatment of neutropenia. The detailed uses of Peg-Religrast 6Mg/0.6Ml Inj are as follows:</p><ul><li><strong>Prevents Chemotherapy-Induced Neutropenia:</strong> Peg-Religrast 6Mg/0.6Ml Inj helps stimulate the formation of neutrophils (a type of white blood cell) in cancer patients receiving chemotherapy.</li><li><strong>Reduces Infection Risk:</strong> By increasing white blood cells, Peg-Religrast 6Mg/0.6Ml Inj helps lower the chances of infections during chemotherapy, when the immune system is weakened.</li><li><strong>Reduces Febrile Neutropenia Risk:</strong> Peg-Religrast 6Mg/0.6Ml Inj helps prevent febrile neutropenia (fever with low neutrophil count), a serious complication of chemotherapy.</li><li><strong>Additional Therapeutic Applications:</strong> Peg-Religrast 6Mg/0.6Ml Inj may be prescribed to boost white blood cell count following bone marrow transplantation, severe persistent neutropenia, neutropenia in HIV patients, and before stem cell donation.</li></ul>
Medicinal Benefits:
Peg-Religrast 6Mg/0.6Ml Inj contains 'Pegfilgrastim,' which is a growth factor. It belongs to the cytokine family of proteins and is extremely similar to a natural protein (granulocyte-colony stimulating factor) produced by the body. Peg-Religrast 6Mg/0.6Ml Inj acts by encouraging the bone marrow to generate more white blood cells, aiding infection resistance. Peg-Religrast 6Mg/0.6Ml Inj is used to boost white blood cell count following cancer treatment or chemotherapy, bone marrow transplantation, severe persistent neutropenia, neutropenia in HIV patients, and before stem cell donation.
FAQs
Peg-Religrast 6Mg/0.6Ml Inj belongs to the class of medicine called 'hematopoietic agent' used to treat neutropenia, a deficiency of specific white blood cells caused by cancer, bone marrow transplant, chemotherapy, or other diseases.
Peg-Religrast 6Mg/0.6Ml Inj contains 'Pegfilgrastim,' which is a growth factor that stimulates the formation of white blood cells and helps to reduce the chances of infection in cancer patients receiving chemotherapy.
This medication should not be used in individuals who have a known allergy to filgrastim, pegfilgrastim, or any of the inactive components present in it.
Yes, Peg-Religrast 6Mg/0.6Ml Inj may interfere with certain lab tests, such as bone imaging and blood testing, potentially resulting in incorrect test findings. Make sure your doctor and laboratory personnel are aware that you take Peg-Religrast 6Mg/0.6Ml Inj.
Peg-Religrast 6Mg/0.6Ml Inj may sometimes cause capillary leak syndrome, a condition that causes blood leakage from small blood vessels. Inform your doctor immediately if you notice difficulty breathing, swelling, a feeling of fullness, and tiredness.
